Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce
Ano de publicação: 2020
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in the prevention of COVID-19 infection or transmission. Within each recommendation, the patient population of interest is specified.
Clinical Diagnosis/diagnosis, Betacoronavirus/drug effects, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Hypoxia/diagnosis, Patient Acuity, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Dexamethasone/therapeutic use, Breast Feeding, Antiviral Agents/therapeutic use, Hydroxychloroquine/therapeutic use, Colchicine/therapeutic use, Plasma/immunology, Darunavir/therapeutic use, Interferons/therapeutic use, Evidence-Based Practice/methods